Therapeutic options for elderly patients with advanced non-small cell lung cancer

Eric J. Avery, Anne Kessinger, Apar Kishor Ganti

Research output: Contribution to journalReview article

19 Scopus citations

Abstract

Elderly patients with advanced non-small cell lung cancer (NSCLC) are at higher risk for adverse events related to treatment of their disease. Chemotherapeutic agents used alone or together may increase survival, while leading to increased treatment related morbidity. New targeted agents used to treat NSCLC have yet to show sufficient improvement in disease outcomes. This review will discuss the current management of elderly patients with advanced non-small cell lung cancer.

Original languageEnglish (US)
Pages (from-to)340-344
Number of pages5
JournalCancer Treatment Reviews
Volume35
Issue number4
DOIs
StatePublished - Jun 1 2009

Keywords

  • Elderly
  • NSCLC
  • Non-small cell lung cancer
  • Treatment

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Therapeutic options for elderly patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.

  • Cite this